FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs
This
week, PharmaCompass brings you key highlights of the US Food and Drug Administration’s D
Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments
This year has seen pivotal advancements in medical innovation. The US Food and Drug Administration (

Market Place
Sourcing Support